SIMULATION OF IV DRUG INTERVENTIONS ON HIV INFECT/AIDS
SIMULATION OF IV DRUG INTERVENTIONS ON HIV INFECT/AIDS
批准号:
3211260
负责人:
Philip C Cooley
金额:
$29.41万
依托单位国家:
美国
项目类别:
财政年份:
1987
资助国家:
美国
项目状态:
已结题
起止时间:
1987-09-30 至 1992-08-31
关键词:
AIDS AIDS education /prevention AIDS therapy HIV infections antiAIDS agent communicable disease transmission disease /disorder prevention /control disease /disorder proneness /risk drug abuse education drug abuse information system education evaluation /planning epidemiology hemophilia As homosexuals human mortality human therapy evaluation information systems intravenous drug abuse mathematical model model design /development sex behavior zidovudine
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The major objectives of the proposed research are to: revise the model we
have previously developed to incorporate recent advances in knowledge of
the epidemiology of HIV/AIDS and changes introduced by both drug
prophylaxis/treatment and behavioral change; use the model to explore and
expand our understanding of the natural history of HIV/AIDS with particular
emphasis on establishing rate of disease progression in IVDUs; and perform
a set of policy analyses that would allow HIV prevention approaches to be
evaluated in the context of drug treatment and/or HIV counseling programs.
Recent use of antivirals and prophylactic measures have altered the
incubation and survival functions--crucial parameters for any model that
will be used for forecasting HIV and AIDS prevalence. Using data which
have become available from the National Institute of Allergies and
Infectious Diseases (NIAID) under the AIDS Clinical Trials Coordinating
Center project, we propose to revise these parameters and make short-term
forecasts of HIV seroprevalence and AIDS incidence.
Two other sources of data are NIDA's AIDS Targeted Outreach Program and
CDC's HIV counseling and Treatment Evaluation Study. Interventions under
these program will yield data on changes in drug-use behavior and sexual
practices. These changes are especially relevant for intravenous drug
abusers. When details on drug abuse behavior are supplied to the revised
model, the effect of various intervention strategies on the current
epidermic will be evaluated.
The HIV/AIDS prevalence model developed by RTI includes the following
characteristics: all primary risk groups are represented; risk group size
is based on AIDS incidence data that accounts for risk behaviors, thereby
estimating only those with high risk behaviors; and contacts that result in
infection are treated as endogenous model parameters so that changes in
risk group behavior are implicitly measured. As a result, the model avoids
the pitfalls of many of the models reported in the literature that treat
contact rate a known exogenous parameters.
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
The assumption of no long reporting delays may result in underestimates of US AIDS incidence.
假设没有长期报告延迟可能会导致美国艾滋病发病率的低估。
DOI:
10.1097/00002030-199310000-00012
发表时间:
1993
期刊:
AIDS (London, England)
影响因子:
--
作者:
[Cooley,PC, Hamill,DN, Myers,LE, Liner,EC]
通讯作者:
Liner,EC
How can results of longitudinal studies help mathematicians model the HIV epidemic among intravenous drug abusers and the general population?
纵向研究的结果如何帮助数学家模拟静脉注射毒品滥用者和普通人群中的艾滋病毒流行情况?
DOI:
--
发表时间:
1991
期刊:
NIDA research monograph
影响因子:
--
作者:
[Cooley,PC, Hamill,DN, Reade-Christopher,SJ, Liner,EC, vanderHorst,CM]
通讯作者:
vanderHorst,CM
MIDAS ITR Extension
-
批准号:8848244
-
项目类别:
-
资助金额:$9.96万
-
财政年份:2014
-
负责人:Philip C Cooley
-
依托单位:
Modeling of Infectious Disease Agent Study Information Technology
-
批准号:8481558
-
项目类别:
-
资助金额:$190.71万
-
财政年份:2009
-
负责人:Philip C Cooley
-
依托单位:
SIMULATION OF IV DRUG EFFECTS ON HIV INFECTIONS AND AIDS
-
批准号:3211259
-
项目类别:
-
资助金额:$22.02万
-
财政年份:1987
-
负责人:Philip C Cooley
-
依托单位:
IMULATION OF IV DRUG INTERVENTIONS ON HIV INFECTIONS &
-
批准号:3211258
-
项目类别:
-
资助金额:$28.87万
-
财政年份:1987
-
负责人:Philip C Cooley
-
依托单位:
SIMULATION OF IV DRUG EFFECTS ON HIV INFECTIONS AND AIDS
-
批准号:3211255
-
项目类别:
-
资助金额:$18.51万
-
财政年份:1987
-
负责人:Philip C Cooley
-
依托单位:
海外基金